Market Tracker

10/31 5:45pm ET

Repligen Corp (NASDAQ:RGEN)

During the Trading Day
25.22 -0.27 / -1.06%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
25.22 +0.003 / +0.01%
 
Volume: 20.3K
No recent news for Repligen Corp.

Today’s Trading

Previous close25.49
Today’s open26.22
Day’s range25.15 - 26.75
Volume530,391
Average volume (3 months)395,488
Market cap$832.2M
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+11.11%
Earnings growth (this year)-46.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+9.48%
P/E ratio50.4
Price/Sales6.34
Price/Book7.83

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...+0.27+1.21%
ENTAEnanta Pharmaceutica...-1.18-2.67%
RGLSRegulus Therapeutics...+1.66+9.07%
TTPHTetraphase Pharmaceu...-1.29-5.12%
Data as of 4:02pm ET, 10/31/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)$0.04
Annual revenue (last year)$68.2M
Annual profit (last year)$16.1M
Net profit margin23.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts